The JAK2V617F mutation is a target for specific T cells in the JAK2V617F-positive myeloproliferative neoplasms

被引：47
|
作者：
Holmstrom, M. O. [1 ,2 ]
Hjortso, M. D. [2 ]
Ahmad, S. M. [2 ]
Met, O. [2 ,3 ]
Martinenaite, E. [2 ]
Riley, C. [1 ]
Straten, P. [2 ]
Svane, I. M. [2 ,3 ]
Hasselbalch, H. C. [1 ]
Andersen, M. H. [2 ,4 ]
机构：
[1] Zealand Univ Hosp, Dept Hematol, Roskilde, Denmark
[2] Univ Copenhagen, Dept Hematol, Ctr Canc Immune Therapy, Herlev Hosp, Herlev, Denmark
[3] Univ Copenhagen, Dept Oncol, Herlev Hosp, Herlev, Denmark
[4] Univ Copenhagen, Dept Immunol & Microbiol, Copenhagen, Denmark
来源：
LEUKEMIA | 2017年 / 31卷 / 02期
关键词：
POLYCYTHEMIA-VERA; ESSENTIAL THROMBOCYTHEMIA; DISORDERS; JAK2;
D O I：
10.1038/leu.2016.290
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：495 / 498
页数：5
相关论文
共 50 条
  • [1] The JAK2V617F mutation is a target for specific T cells in the JAK2V617F-positive myeloproliferative neoplasms
    M O Holmström
    M D Hjortsø
    S M Ahmad
    Ö Met
    E Martinenaite
    C Riley
    P Straten
    I M Svane
    H C Hasselbalch
    M H Andersen
    Leukemia, 2017, 31 : 495 - 498
  • [2] JAK2V617F mutation and thrombosis in the myeloproliferative neoplasms
    Demirkan, F.
    Kalkan, S.
    Kahraman, S.
    Tunali, S.
    Katgi, A.
    Piskin, O.
    Ozcan, M. A.
    Ozsan, H. G.
    Undar, B.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 890 - 890
  • [3] Thrombosis in Myeloproliferative Neoplasms With JAK2V617F Mutation
    Sun, Tiantian
    Zhang, Lei
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2013, 19 (04) : 374 - 381
  • [4] Jak2V617F Reversible Activation Shows an Essential Requirement for Jak2V617F in Myeloproliferative Neoplasms (MPNs)
    Dunbar, Andrew
    Bowman, Robert L.
    Park, Young
    Izzo, Franco
    Myers, Robert M.
    Karzai, Abdul
    Kim, Won Jun
    Maestre, Ines Fernandez
    Waarts, Michael R.
    Nazir, Abbas
    Xiao, Wenbin
    Brodsky, Max
    Farina, Mirko
    Cai, Louise
    Cai, Sheng F.
    Wang, Benjamin
    An, Wenbin
    Yang, Julie
    Mowla, Shoron
    Eisman, Shira E.
    Mishra, Tanmay
    Houston, Remie
    Guzzardi, Emily
    Benitez, Anthony R. Martinez
    Viny, Aaron D.
    Koche, Richard
    Landau, Dan A.
    Levine, Ross L.
    BLOOD, 2022, 140
  • [5] JAK2V617F-Positive Endothelial Cells Induce Apoptosis and Release JAK2V617F-Positive Microparticles
    Hekimoglu, Hilal
    Toprak, Selin Fulya
    Sozer, Selcuk
    TURKISH JOURNAL OF HEMATOLOGY, 2022, 39 (01) : 13 - 21
  • [6] Underlying mechanisms of the JAK2V617F mutation in the pathogenesis of myeloproliferative neoplasms
    Mullally, A.
    PATHOLOGE, 2016, 37 : 175 - 179
  • [7] JAK2V617F-positive endothelial cells contribute to clotting abnormalities in myeloproliferative neoplasms
    Etheridge, S. Leah
    Roh, Michelle E.
    Cosgrove, Megan E.
    Sangkhae, Veena
    Fox, Norma E.
    Chen, Junmei
    Lopez, Jose A.
    Kaushansky, Kenneth
    Hitchcock, Ian S.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (06) : 2295 - 2300
  • [8] Reversine exhibits antineoplastic activity in JAK2V617F-positive myeloproliferative neoplasms
    Lima, Keli
    Elias Godoy Carlos, Jorge Antonio
    Alves-Paiva, Raquel de Melo
    Vicari, Hugo Passos
    de Souza Santos, Fabio Pires
    Hamerschlak, Nelson
    Costa-Lotufo, Leticia Veras
    Traina, Fabiola
    Machado-Neto, Joao Agostinho
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [9] Reversine exhibits antineoplastic activity in JAK2V617F-positive myeloproliferative neoplasms
    Keli Lima
    Jorge Antonio Elias Godoy Carlos
    Raquel de Melo Alves-Paiva
    Hugo Passos Vicari
    Fábio Pires de Souza Santos
    Nelson Hamerschlak
    Leticia Veras Costa-Lotufo
    Fabiola Traina
    João Agostinho Machado-Neto
    Scientific Reports, 9
  • [10] JAK2V617F-Mutant Vascular Niche Promotes JAK2V617F Clonal Expansion in Myeloproliferative Neoplasms
    Zhan, Huichun
    Lin, Chi Hua Sarah
    Segal, Yarden
    Kaushansky, Kenneth
    BLOOD, 2016, 128 (22)
12345